Skip to main content
. Author manuscript; available in PMC: 2020 Dec 26.
Published in final edited form as: J Alzheimers Dis. 2019;71(Suppl 1):S95–S103. doi: 10.3233/JAD-181227

Table 3.

Results of Linear mixed effect models of gait abnormalities and their association with cognitive decline in 81 individuals with any MCR subtype. See explanation of Model in Methods

Variables Cognitive decline* Adjusted estimate, (95% CI), p-value Functional decline* Adjusted estimate, (95% CI), p-value
Any gait abnormality 1.03 (−6.85–4.79), 0.728 0.84 (0.21–1.47), 0.010
Time −0.67 (−1.42–0.07), 0.076 0.00 (−0.12–0.12), 0.951
Any gait abnormality × Time 0.95 (−0.03–1.93), 0.056 0.17 (0.01–0.33), 0.033
Neurological gaits −2.47 (−8.14–3.20), 0.391 0.18 (−0.51–0.87), 0.611
Time −0.26 (−0.87–0.34), 0.386 0.12 (0.02–0.22), 0.015
Neurological gaits × Time 0.51 (−0.65–1.67), 0.386 −0.10 (−0.29–0.09), 0.302
Non-Neurological gaits −0.68 (−6.20–4.83), 0.806 0.85 (0.26–1.44), 0.005
Time −0.27 (−0.96–0.43), 0.448 0.00 (−0.10–0.11), 0.938
Non-neurological gaits × Time 0.33 (−0.72–1.37), 0.534 0.22 (0.06–0.38), 0.008
*

Adjusted for age, sex, education years, ethnicity and comorbidity index.